The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on CLN, Financial Update & Strategic Review

5 Feb 2024 07:00

RNS Number : 9418B
Bidstack Group PLC
05 February 2024
 

Certain information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR") as applied in the United Kingdom. Upon publication of this Announcement, this information is now considered to be in the public domain.

 5 February 2024

Bidstack Group Plc

("Bidstack" or the "Company" or the "Group")

Update on Loan Agreement with Irdeto B.V, Financial Update and Strategic Review

Bidstack Group Plc (AIM: BIDS) is providing an update on the loan agreement and ancillary documents announced on 18 October 2023 ("CLN") with strategic investor Irdeto B.V. ("Irdeto"), a financial update and information about the Board's decision to initiate a strategic review. 

 

Loan Agreement with Irdeto

 

On 18 October 2023, the Company announced that it had agreed to enter into the CLN with Irdeto. In order to enable Irdeto to utilise the CLN, drawdown of the further tranches of the Loan Agreement, beyond the initial tranche taken on or around the date of execution of the CLN, was conditional on both (i) the approval by the Company's shareholders of a share capital reorganisation; and (ii) the approval of a waiver of Rule 9 ("Rule 9 Waiver") of the City Code on Takeovers and Mergers ("City Code") by the Panel on Takeovers and Mergers ("the Panel") and the independent shareholders of the Company, voting on a poll, in a general meeting (because, if the drawdowns of the loan facility within the CLN were fully taken, at the earliest possible opportunity, and the Company made no cash repayments, Irdeto could own in excess of 50% of the TVR of the Company therefore, pursuant to the terms of the CLN, the Company was required to seek the approval of the Rule 9 Waiver from the Panel.).

 

To obtain approval from the Panel, the Company is required to submit a draft shareholder circular to the Panel containing all information required by the Panel in relation to the Rule 9 Waiver. In order to provide the Company with the requisite information within its circular, Irdeto had sought to obtain the required disclosures from its parent company, Multichoice Group Limited (JHB:MCG) ("Multichoice"). 

 

As at the date hereof, Irdeto has not obtained the appropriate disclosures and requisite documentation from Multichoice and its board of directors and as a result the Company has not been able to submit its draft circular and notice of general meeting to the Panel for review.

 

Financial update

The Settlement and new commercial partnership with Azerion was announced on the 22 December 2023. Payments totalling EUR 3m have been made by Azerion in consideration of both the full and final settlement to resolve all outstanding claims and disputes and the establishment and activation of a new technical and commercial collaboration between the companies. Both companies are moving forward collaboratively and will work together on a non-exclusive basis.

To date, Bidstack has drawn down one tranche of £0.6m from the CLN and, as a result of the delays stated above, does not currently expect to make any further draw downs. Despite the recent receipt of the cash settlement reached with Azerion the Group's working capital position remains tight and will need further working capital in the short term.

 

The Group has continued to manage its cash resources very carefully. At 31 January 2024 the Group's unaudited cash balance was approximately £1.4m which, without further external funding, and assuming the Company cannot utilise any more funds from the CLN, the Group only has sufficient cash resources until the end of March 2024.

 

Strategic Review

 

Whilst the Company is keen to continue to work with Irdeto as previously announced, the Board of the Company feels that it must also consider other funding alternatives and has decided to initiate a strategic review. The Board has appointed Alvarez & Marsal Europe LLP, a restructuring adviser who, alongside the Company and its other advisers, will look at all options for the future of the Group which may or may not involve a sale of the Company's assets.

 

Further announcements will be made in due course.

 

-ENDS-

 

Contacts

Bidstack Group Plc

James Draper, CEO

 

via SPARK

SPARK Advisory Partners Limited (Nominated Adviser)

Mark Brady / Neil Baldwin / James Keeshan

+44 (0) 203 368 3550

Stifel Nicolaus Europe Limited (Broker)

Fred Walsh / Tom Marsh

 

+44 (0) 20 7710 7600

Alvarez & Marsal Europe LLP (Restructuring Adviser)

London Office

+44 (0) 20 7715 5200

 

Notes to editors

About Bidstack

Bidstack's technology empowers video game publishers to monetise and manage spaces within their virtual environments. Its platform provides real-time reporting, dynamic targeting and player communication tools for brand activations and fan engagement.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUWCPUPCGAC
Date   Source Headline
27th Jul 20165:35 pmRNSHolding(s) in Company
25th Jul 20168:45 amRNSShare Option Schemes & Grant of Options
22nd Jul 20164:05 pmRNSResult of AGM & Result of General Meeting
21st Jul 20162:30 pmRNSFunding Update & Directors Participation
20th Jul 20165:15 pmRNSConditional Result of Open Offer
29th Jun 20169:45 amRNSNotice of 2016 Annual General Meeting and Posting
29th Jun 20167:01 amRNSProposed Fundraising and Loan Capitalisation
29th Jun 20167:00 amRNSBoard Changes
13th Jun 20167:10 amRNSFurther Working Capital Loan
13th Jun 20167:00 amRNSPreliminary Announcement of Results for 2015
8th Jun 20164:17 pmRNSHolding(s) in Company
22nd Mar 20167:00 amRNSSuccessful Customer Rollout With Strategic Partner
8th Feb 20167:00 amRNSLitigation Settlement
11th Jan 20167:00 amRNSAppointment of Non-Executive Director
30th Dec 20152:00 pmRNSTrading Update
23rd Dec 20151:00 pmRNSWorking Capital Raise
11th Dec 20154:15 pmRNSHolding(s) in Company
1st Dec 20157:00 amRNSBoard and Management Changes
23rd Nov 20157:00 amRNSLaunches Kiqplan Health & Fitness Training App
29th Oct 20157:00 amRNSHolding(s) in Company
19th Oct 20159:01 amRNSBoard Changes
30th Sep 20159:35 amRNSInterim Results
4th Sep 20152:30 pmRNSBoard Changes
27th Aug 20157:01 amRNSAppointment of CEO
10th Aug 20157:00 amRNS£1,665,000 Raised
18th Jun 20157:00 amRNSAgreement with Inflight Retail Specialist
16th Jun 20157:00 amRNSAppointment of Chief Financial Officer
1st Jun 20153:45 pmRNSResult of AGM
27th May 20157:00 amRNSDirectorate Change
12th May 20157:00 amRNSLaunch of four new Kiqplans and retail toolkits
8th May 20157:00 amRNSFinal Results
5th May 20157:01 amRNSPartnership with Tower Watson
29th Apr 20157:00 amRNSPartnership to Promote Employee-wellness
25th Feb 20157:00 amRNSAppeals Decision On Fitbit Trademark Infringement
24th Feb 20157:00 amRNSKiqplan available in Samsung's S Health globally
16th Feb 20157:00 amRNSStock Order by Leading US Midwesr Retailer
13th Feb 20157:00 amRNSTrading Update - H2 2014 Sales up 495%
29th Jan 201510:00 amRNSKiqplan Promotional Programme with Jawbone
27th Jan 20153:03 pmRNSUpdate re Legal Action Against Fitbit Inc
23rd Jan 20157:00 amRNSKiqplan: Partner of Cancer Research Race for Life
6th Jan 20157:00 amRNSAddition of New Functionality to Kiqplan
30th Dec 20147:00 amRNSTotal Voting Rights
19th Dec 20147:00 amRNSNew Contracts with Amazon, Best Buy.com and Target
9th Dec 20147:00 amRNSGBP3.5 million Placing to Accelerate Growth
26th Nov 20147:00 amRNSLoan Extension
14th Nov 20147:00 amRNSKiqplan Partner Agreement with Samsung
7th Nov 20147:00 amRNSLaunch of KiQplan
5th Nov 20144:25 pmRNSBoard Changes
5th Nov 20144:23 pmRNSDirector's Dealings
28th Oct 20142:31 pmRNSFurther Statement re: Share Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.